SHUTTLE PHARMACEUTICALS HOLD (SHPH) Stock Income Statement
USA - NASDAQ:SHPH - US8256934014 - Common Stock
3.47 USD
-0.21 (-5.71%)
4.04 USD
+0.57 (+16.43%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.69M | 7.70M | 5.89M | 2.55M | 1.74M | |||
| Research and Development | 4.99M | 3.62M | 3.52M | 1.49M | 1.02M | |||
| Selling, General, and Administrative Expenses | 6.70M | 4.08M | 2.38M | 1.07M | 720.00K | |||
| Operating Income | -11.69M | -7.70M | -5.89M | -2.55M | -1.74M | |||
| Interest Income/Expense | 219.20K | -585.00K | -118.90K | -880.00K | 530.00K | |||
| Other Income/Expense | N/A | -30.20K | -104.30K | 330.00K | N/A | |||
| Non Recurring Items | -762.20K | -833.50K | -477.20K | 70.00K | 60.00K | |||
| Income Before Taxes | -12.14M | -9.14M | -6.59M | -3.03M | -1.15M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Net Income | -12.14M | -9.14M | -6.59M | -3.10M | -1.26M | |||
| EBITDA | N/A | -7.69M | -5.89M | -2.54M | -1.73M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -64.49 | -79.66 | -88.38 | -45.57 | -18.97 | |||
| Statistics | ||||||||
All data in USD